Font Size: a A A

Dihydromyricetin Ameliorates Atherosclerosis In LDL Receptor Deficient Mice And Its Possible Mechanisms

Posted on:2018-07-26Degree:MasterType:Thesis
Country:ChinaCandidate:T T LiuFull Text:PDF
GTID:2334330569495358Subject:Pharmacy
Abstract/Summary:PDF Full Text Request
Background and aims:Dihydromyricetin(DMY),the most abundant flavonoid in Ampelopsis grossedentata,exerts numerous pharmacological activities,including anti-inflammatory,antioxidant,hepatoprotective,and lipid regulatory;however,its protective effect against atherosclerosis remains poorly understood.The aim of the present study was to evaluate the effects of DMY on high fat diet group(HFD)-induced atherosclerosis using LDL receptor deficient(LDLr-/-)mice.Methods:The blood samples were collected for serum lipid profiles,oxidized LDL(ox-LDL)and pro-inflammatory cytokines determination.Histology,hepatic lipid content,quantification of atherosclerosis,assessment of oxidative stress and inflammation were performed on liver and aorta samples by methods of molecular biology.The effect of DMY on ox-LDL-induced human umbilical vein endothelial cells(HUVECs)dysfunction was further studied.Results:1)DMY slightly reduced the weight of HFD-fed LDLr-/-mice,but there was no significant difference;2)DMY ameliorated the content of TC,TG and LDL-c and reduced serum ox-LDL,IL-6 and TNF-αlevel in HFD-fed LDLr-/-mice;3)DMY suppressed hepatic lipid accumulation and increased protein expressions of PPARa,LXRa and ABCA1;4)DMY ameliorated inflammation reaction and reduced mRNA level of CD68,IL-6,TNF-αin HFD-fed LDLr-/-mice;5)DMY inhibited atherosclerotic lesion formation and favoured features of plaque stability;6)DMY prevented hepatic and aortic inflammation by reducing IL-6 and TNF-αmRNA expression;7)DMY prevented hepatic and aortic oxidative stress by normalizing activities of antioxidant enzymes in liver and suppressing reactive oxygen species generation and NOX2 protein expression in both liver and aorta;8)DMY inhibited ox LDL-induced injury,monocytes adhesion,apoptosis and oxidative stress in HUVECs.Conclusions:These findings suggest that DMY could reduce atherosclerosis via its pleiotropic effects,including improvement of endothelial dysfunction,amelioration of lipid profiles,anti-inflammatory action and anti-oxidative effect.
Keywords/Search Tags:Dihydromyricetin, Atherosclerosis, Anti-oxidation, Anti-inflammation
PDF Full Text Request
Related items